Citadel Advisors’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-201,002
Closed -$12.1M 9568
2015
Q2
$10.5M Buy
201,002
+114,854
+133% +$5.66M 0.01% 1444
2015
Q1
$3.63M Buy
86,148
+81,126
+1,615% +$3.71M ﹤0.01% 2378
2014
Q4
$209K Sell
5,022
-9,098
-64% -$359K ﹤0.01% 5935
2014
Q3
$554K Sell
14,120
-3,664
-21% -$121K ﹤0.01% 4478
2014
Q2
$511K Buy
+17,784
New +$503K ﹤0.01% 4355

Citadel Advisors's ZSPH Position: Q3 2015 in Review

Citadel Advisors sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q3 2015, closing a stake of 201,002 shares — an estimated $12.1M sold.

Citadel Advisors first reported a position in ZSPH in Q2 2014 and held it in 5 quarters. The position peaked at $10.5M in Q2 2015. 124 funds tracked by Wall St. Rank hold ZSPH as of Q3 2015.

  • Citadel Advisors reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q3 2015 after selling out during the quarter.
  • Citadel Advisors sold 201,002 ZS PHARMA INC COMS TK (DE) shares in Q3 2015, an estimated $12.1M.
  • Citadel Advisors first reported a position in ZS PHARMA INC COMS TK (DE) in Q2 2014 and held it in 5 quarters.
  • Citadel Advisors's ZS PHARMA INC COMS TK (DE) position peaked at $10.5M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q3 2015.

Based on Citadel Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.